Human medicines European public assessment report (EPAR): Avzivi, bevacizumab, Date of authorisation: 26/07/2024, Revision: 2, Status: Authorised

Procedural advice for vaccine platform technology master file (vPTMF) certification

Procedural advice for veterinary vaccine antigen master file (VAMF) certification

Human medicines European public assessment report (EPAR): Tocilizumab STADA (previously Tofidence), tocilizumab, Date of authorisation: 20/06/2024, Revision: 4, Status: Authorised

HMPC meeting report on European Union herbal monographs, guidelines and other activities - 19-21 January 2026

European Medicines Agency’s data protection notice for EudraVigilance Human (EV)

Human medicines European public assessment report (EPAR): Prevenar 13, pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed), Date of authorisation: 09/12/2009, Revision: 50, Status: Authorised

Start of procedure: Extension of marketing authorisation (12 December 2025 - 29 January 2026)

Start of procedure: Type II Variation - Extension of indication under evaluation by the CHMP (12 December 2025 - 29 January 2026)

Industry stakeholder webinar on revised environmental risk assessment guideline for medicinal products for human use - 1 year experience, Online, European Medicines Agency, Amsterdam, the Netherlands, from 6 October 2025, 14:30 (CEST) to 6 October 2025, 17:00 (CEST)